Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.
Tan DJH, Ng CH, Lin SY, Pan XH, Tay P, Lim WH, Teng M, Syn N, Lim G, Yong JN, Quek J, Xiao J, Dan YY, Siddiqui MS, Sanyal AJ, Muthiah MD, Loomba R, Huang DQ. Tan DJH, et al. Among authors: tay p. Lancet Oncol. 2022 Apr;23(4):521-530. doi: 10.1016/S1470-2045(22)00078-X. Epub 2022 Mar 4. Lancet Oncol. 2022. PMID: 35255263 Free PMC article.
Placebo effect on progression and regression in NASH: Evidence from a meta-analysis.
Ng CH, Xiao J, Lim WH, Chin YH, Yong JN, Tan DJH, Tay P, Syn N, Foo R, Chan M, Chew N, Tan EX, Huang DQ, Dan YY, Tamaki N, Siddiqui MS, Sanyal AJ, Loomba R, Noureddin M, Muthiah MD. Ng CH, et al. Among authors: tay p. Hepatology. 2022 Jun;75(6):1647-1661. doi: 10.1002/hep.32315. Epub 2022 Jan 24. Hepatology. 2022. PMID: 34990037 Review.
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.
Tang ASP, Chan KE, Quek J, Xiao J, Tay P, Teng M, Lee KS, Lin SY, Myint MZ, Tan B, Sharma VK, Tan DJH, Lim WH, Kaewdech A, Huang D, Chew NW, Siddiqui MS, Sanyal AJ, Muthiah M, Ng CH. Tang ASP, et al. Among authors: tay p. Clin Mol Hepatol. 2022 Jul;28(3):483-496. doi: 10.3350/cmh.2021.0406. Epub 2022 Mar 2. Clin Mol Hepatol. 2022. PMID: 35232007 Free PMC article.
Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis.
Ng CH, Muthiah MD, Xiao J, Chin YH, Lim G, Lim WH, Tay P, Tan DJH, Yong JN, Pan XH, Koh JWH, Chew N, Syn N, Tan E, Huang DQ, Siddiqui MS, Loomba R, Sanyal AJ, Noureddin M. Ng CH, et al. Among authors: tay p. Aliment Pharmacol Ther. 2022 May;55(9):1076-1087. doi: 10.1111/apt.16808. Epub 2022 Mar 14. Aliment Pharmacol Ther. 2022. PMID: 35285529
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals.
Quek J, Ng CH, Tang ASP, Chew N, Chan M, Khoo CM, Wei CP, Chin YH, Tay P, Lim G, Tan DJH, Lim WH, Chan KE, Teng M, Tan E, Tamaki N, Huang DQ, Siddiqui MS, Young DY, Noureddin M, Muthiah MD. Quek J, et al. Among authors: tay p. Endocr Pract. 2022 Jul;28(7):667-672. doi: 10.1016/j.eprac.2022.03.016. Epub 2022 Mar 29. Endocr Pract. 2022. PMID: 35364328
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals.
Chan KE, Koh TJL, Tang ASP, Quek J, Yong JN, Tay P, Tan DJH, Lim WH, Lin SY, Huang D, Chan M, Khoo CM, Chew NWS, Kaewdech A, Chamroonkul N, Dan YY, Noureddin M, Muthiah M, Eslam M, Ng CH. Chan KE, et al. Among authors: tay p. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2691-2700. doi: 10.1210/clinem/dgac321. J Clin Endocrinol Metab. 2022. PMID: 35587339
A meta-analysis of prevalence of diabetic retinopathy in Asia.
Yaow CY, Lin SY, Xiao J, Koh JH, Yong JN, Tay PW, Tan ST. Yaow CY, et al. Minerva Endocrinol (Torino). 2022 Feb 23. doi: 10.23736/S2724-6507.21.03585-5. Online ahead of print. Minerva Endocrinol (Torino). 2022. PMID: 35195381
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis.
Lim WH, Tay P, Ng CH, Tan DJH, Ong C, Koh JH, Teng M, Chee D, Wong ZY, Kawaguchi T, Takahashi H, Muthiah M, Tan EXX, Wijarnpreecha K, Lee GH, Noureddin M, Lee BP, Mathurin P, Loomba R, Huang DQ. Lim WH, et al. Among authors: tay p. Aliment Pharmacol Ther. 2024 Mar;59(6):730-741. doi: 10.1111/apt.17888. Epub 2024 Feb 1. Aliment Pharmacol Ther. 2024. PMID: 38303565 Review.
103 results